Original Research

Rosacea is among the most prevalent dermatoses in the United States, with an estimated prevalence of approximately 16 million affected individuals.
The Challenge of Rosacea Treatment
In recent years, several health plans in the Health Insurance Marketplace exchange were offering free doctors’ visits to their members, with the hope of identifying illnesses before they become more difficult or more expensive to treat.
Patients’ Choice for Site of Care Motivated by More Than Cost Alone
Chronic noncancer pain is a common and debilitating condition that affects approximately 30% of adults in the United States. The management of chronic pain is primarily aimed at relieving the pain and improving physical and emotional functions, although these are not achieved in a substantial number of patients.
The Opioid Epidemic: Healthcare Utilization and Cost Considerations
Chronic obstructive pulmonary disease (COPD) is characterized by declining lung function attributable to a combination of airway obstruction and inflammation.
When an Outcome Is Overdetermined: Nonadherence, Utilization, and the Impetus for Research in COPD
Breast cancer, the most common malignancy in women in the United States, is a serious disease associated with substantial medical and economic burden.
An Ounce of Prevention Is Not a Choice a Patient Gets to Make for Late-Stage Cancer
Chronic myelogenous leukemia (CML) is a hematologic cancer that occurs primarily in adults. Although CML can occur at any age, the median age at diagnosis is 64 years, and the incidence increases with age.
Generic Imatinib: Can It Provide Significant Cost Relief for Patients?
For many years, disease­modifying antirheumatic drugs (DMARDs) have been the mainstay of RA treatment, reducing inflammation and preventing further joint deterioration and disease progression. In the past 15 years, biologic DMARDs have become available and have proved effective for reducing inflammation and managing the disease.
You Cannot Manage What You Cannot Measure
Although varicose veins are considered by some policymakers to primarily be an aesthetic concern, varicosities and their resulting sequelae are primary contributors to the morbidity associated with chronic venous diseases.
A Teachable Moment in Health Benefits Design
Improving medication adherence among individuals with anxiety or depression requires special considerations.
Counting on a Run of Value-Based Benefit Design
Response-Guided Therapy an Appropriate Tool for Evaluating Treatment Protocols and Costs of Drug Therapies
Page 1 of 2
Results 1 - 10 of 19
  •  Association for Value-Based Cancer Care
  • Value-Based Cancer Care
  • Value-Based Care in Rheumatology
  • Oncology Practice Management
  • Rheumatology Practice Management
  • Urology Practice Management
  • Inside Patient Care: Pharmacy & Clinic
  • National Association of Specialty Pharmacy
  • Lynx CME